"10.1371_journal.pone.0123443","plos one","2015-04-09T00:00:00Z","Andreas Jodal; Fabienne Pape; Christoph Becker-Pauly; Ole Maas; Roger Schibli; Martin Béhé","Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen, Switzerland; Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland; Institute of Biochemistry, University of Kiel, Kiel, Germany; Department of Radiology and Nuclear Medicine, Division of Nuclear Medicine, University Hospital Basel, Basel, Switzerland","Conceived and designed the experiments: AJ MB. Performed the experiments: AJ FP OM CBP MB. Analyzed the data: AJ FP CBP RS MB. Contributed reagents/materials/analysis tools: CBP. Wrote the paper: AJ MB.","Patent disclosure: Martin Béhé declares that he is an inventor of the patent: Invention affecting GLP-1 and exendin. Philipps-Universität Marburg, June 17th 2009. All other authors declare that they have no conflict of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","04","Andreas Jodal","AJ",6,TRUE,2,5,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
